CDH13 genotype-dependent association of high-molecular weight adiponectin with all-cause mortality: The j-shipp study

Diabetes Care

Volumn 37, Issue 2, 2014, Pages 396-401

  Uetani, Eri ^a   Tabara, Yasuharu ^a,b   Kawamoto, Ryuichi ^a   Onuma , Hiroshi ^a   Kohara, Katsuhiko ^a   Osawa, Haruhiko ^a   Miki, Tetsuro ^a  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; CADHERIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; T CADHERIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; H-CADHERIN;

ADULT; AGE; AGED; ALLELE; ARTICLE; ASSAY; BODY WEIGHT; CDH13 GENE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; GENE; GENE INTERACTION; GENETIC CODE; GENOTYPE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; HYPERTENSION; JAPANESE; LIPOPROTEIN BLOOD LEVEL; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; MIDDLE AGED; MOLECULAR WEIGHT; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PROGNOSIS; PROTEIN BLOOD LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM; TAQMAN PROBE ASSAY; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; CAUSE OF DEATH; EPIDEMIOLOGY; GENETICS; JAPAN;

ADIPONECTIN; ADULT; ALLELES; CADHERINS; CAUSE OF DEATH; CHOLESTEROL, HDL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HUMANS; JAPAN; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MOLECULAR WEIGHT; POLYMORPHISM, SINGLE NUCLEOTIDE; TRIGLYCERIDES;

EID: 84893049559     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc13-1658     Document Type: Article

References (30)

1. Turer AT, Scherer PE. Adiponectin: mechanistic insights and clinical implications. Diabetologia 2012;55:2319-2326
2. Li S, Shin HJ, Ding EL, van Dam RM. Adiponectin levels and risk of type 2 diabetes: a systematic review and metaanalysis.JAMA 2009;302:179-188
3. Tabara Y, Osawa H, Kawamoto R, et al. Reduced high-molecular-weight adiponectin and elevated high-sensitivity C-reactive protein are synergistic riskfactors for metabolic syndrome in a largescale middle-aged to elderly population:the Shimanami Health Promoting Program Study. J Clin Endocrinol Metab 2008;93: 715-722
4. Iglseder B, Mackevics V, Stadlmayer A, Tasch G, Ladurner G, Paulweber B. Plasma adiponectin levels and sonographic phenotypes of subclinical carotid artery atherosclerosis: data from the SAPHIR Study. Stroke 2005;36:2577-2582
5. Kizer JR, Benkeser D, Arnold AM, et al. Total and high-molecular-weight adiponectin and risk of coronary heart disease and ischemic stroke in older adults. J ClinEndocrinol Metab 2013;98:255-263
6. Kizer JR, Barzilay JI, Kuller LH, Gottdiener JS. Adiponectin and risk of coronary heart disease in older men and women. J Clin Endocrinol Metab 2008;93:3357-3364
7. Singer JR, Palmas W, Teresi J, Weinstock R, Shea S, Luchsinger JA. Adiponectin and allcause mortality in elderly people with type 2 diabetes. Diabetes Care 2012;35:1858- 1863
8. Kizer JR, Benkeser D, Arnold AM, et al. Associations of total and high-molecularweightadiponectin with all-cause and cardiovascular mortality in older persons:the Cardiovascular Health Study.Circulation 2012;126:2951-2961
9. Poehls J, Wassel CL, Harris TB, et al.; Health ABC Study. Association of adiponectin with mortality in older adults: the Health, Aging,and Body Composition Study. Diabetologia 2009;52:591-595
10. Laughlin GA, Barrett-Connor E, May S, Langenberg C. Association of adiponectin with coronary heart disease and mortality: the Rancho Bernardo study. Am J Epidemiol 2007;165:164-174
11. Cavusoglu E, Ruwende C, Chopra V, et al. Adiponectin is an independent predictor of all-cause mortality, cardiac mortality, andmyocardial infarction in patients presenting with chest pain. Eur Heart J 2006;27:2300- 2309
12. Kistorp C, Faber J, Galatius S, et al. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation 2005;112:1756-1762
13. Sattar N, Nelson SM. Adiponectin, diabetes, and coronary heart disease in older persons: unraveling the paradox. J Clin Endocrinol Metab 2008;93:3299-3301
14. Wu Y, Li Y, Lange EM, et al. Genome-wide association study for adiponectin levels in Filipino women identifies CDH13 and a novel uncommon haplotype at KNG1-ADIPOQ. Hum Mol Genet 2010;19:4955-4964
15. Jee SH, Sull JW, Lee JE, et al. Adiponectin concentrations: a genome-wide association study. Am J Hum Genet 2010; 87:545-552
16. Hug C, Wang J, Ahmad NS, Bogan JS, Tsao TS, Lodish HF. T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin. Proc Natl Acad Sci USA 2004;101:10308-10313
17. Vozarova de Courten B, Hanson RL, Funahashi T, et al. Common polymorphisms in the adiponectin gene ACDC are not associated with diabetes in Pima Indians. Diabetes 2005;54:284-289
18. Pollin TI, Tanner K, O'connell JR, et al. Linkage of plasma adiponectin levels to 3q27 explained by association with variation in the APM1 gene. Diabetes 2005; 54:268-274
19. Heid IM, Henneman P, Hicks A, et al. Clear detection of ADIPOQ locus as the major gene for plasma adiponectin: results of genome-wide association analyses including 4659 European individuals. Atherosclerosis 2010;208:412-420
20. Ling H, Waterworth DM, Stirnadel HA, et al. Genome-wide linkage and association analyses to identify genes influencing adiponectin levels: the GEMS Study. Obesity (Silver Spring) 2009;17:737-744
21. Morisaki H, Yamanaka I, Iwai N, et al. CDH13 gene coding T-cadherin influences variations in plasma adiponectin levels in the Japanese population. Hum Mutat 2012; 33:402-410
22. OnumaH, Tabara Y, Kawamura R, et al. Plasma resistin is associated with single nucleotide polymorphisms of a possible resistin receptor, the decorin gene, in the eneral Japanesepopulation. Diabetes 2013;62:649-652
23. Osawa H, Tabara Y, Kawamoto R, et al. Plasma resistin, associated with single nucleotide polymorphism -420, is correlated with insulin resistance, lower HDL cholesterol, and high-sensitivity C-reactive protein in the Japanese general population. Diabetes Care 2007;30:1501-1506
24. Nakano Y, Tajima S, Yoshimi A, et al. A novel enzyme-linked immunosorbent assay specific for high-molecular-weight adiponectin. J Lipid Res 2006;47:1572- 1582
25. Aso Y, Yamamoto R, Wakabayashi S, et al. Comparison of serum high-molecular weight (HMW) adiponectin with total adiponectin concentrations in type 2diabetic patients with coronary arterydisease using a novel enzyme-linked immunosorbent assay to detect HMW adiponectin. Diabetes 2006;55:1954- 1960
26. World health statistics 2013 [internet], 2013. Geneva, World Health Org. Available from http://www.who.int/gho/publications/world-health-statistics/en/ index.html
27. Kadowaki T, Sekikawa A, Okamura T, et al. igher levels of adiponectin in Americanthan in Japanese men despite obesity. Metabolism 2006;55:1561-1563
28. Nakamura Y, Ueshima H, Okuda N, et al.; INTERLIPID Research Group. Relation of dietary and other lifestyle traits to difference in serum adiponectin concentration of Japanese in Japan and Hawaii: the INTERLIPID Study. Am J Clin Nutr 2008;88:424-430
29. Denzel MS, ScimiaMC, Zumstein PM, Walsh K, Ruiz-Lozano P, Ranscht B. T-cadherin is critical for adiponectin-mediated cardioprotection in mice. J Clin Invest 2010; 120:4342- 4352
30. Dastani Z, Hivert MF, Timpson N, et al.; DIAGRAM+ Consortium; MAGIC Consortium; GLGC Investigators; MuTHER Consortium; DIAGRAM Consortium; GIANT Consortium; Global B Pgen Consortium; Procardis Consortium;MAGIC investigators; GLGC Consortium. Novel loci for adiponectin levels and theirinfluence on type 2 diabetes and metabolic traits: a multi-ethnic metaanalysis of 45,891 individuals. PLoS Genet 2012;8:e1002607